Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Renaissance IPO ETF (NY: IPO )

41.28 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EDT, Sep 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 40.88 (49)
Ask (Size) 42.13 (47)
Prev. Close 41.28
Today's Range 41.28 - 41.28
52wk Range 29.21 - 42.74
Shares Outstanding 35,500
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race
BioAge Labs a biotech company focused on therapies for metabolic diseases, has filed for a $100 million IPO. Founded in 2015, the company plans to list on Nasdaq under the symbol BIOA. Their lead drug,... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
What's Going On With Nu Holdings Stock Today?
Nu added 5.2 million customers in the second quarter, reaching a total of 104.5 million customers globally by June 30, 2024, marking a 25% increase YoY. 
Via Benzinga

Performance

YTD
+14.03%
+14.03%
1 Month
+8.64%
+8.64%
3 Month
+2.81%
+2.81%
6 Month
+0.83%
+0.83%
1 Year
+23.26%
+23.26%

More News

Read More
Supreme Court Allows Merchants To Challenge Debit-Card Swipe Fees Beyond Six-Year Statute
Via Benzinga
ETF Traps: 3 Funds That Promise Much But Deliver Little
Via InvestorPlace
Topics ETFs
3 Interesting IPOs Worth Checking Out In 2024
Via Talk Markets
IPO Activity Slow To Recover
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
These Three September Listings Could Revive The IPO Market
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
This Fintech Was Just Valued at $65 Billion. Could It Become 1 of 2024's Largest IPOs?
Via The Motley Fool
Private Equity Bounces Back: EQT Raises $24B For Deals, Signals Listings Revival
Via Benzinga
IPO Revival In 2024: Plaid, Chime, And Kim Kardashian's Skims Among Potential Market Movers
Via Benzinga
Topics Economy Initial Public Offering
Exposures Interest Rates Securities Market
KKR-Backed BrightSpring Health Services Sets Sail For IPO, Aiming To Curtail Debt
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Weight-Loss Drug Gold Rush Gets Larger As New Player Fractyl Health Files For $100M IPO
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
FAANG+ Leaving Newcomers In The Dust
Via Talk Markets
Topics ETFs Initial Public Offering
Exposures Securities Market
Reddit Is Exploring a 2024 IPO. Could This Be Good News for Investment Banks?
Via The Motley Fool
Topics Initial Public Offering
Exposures Securities Market
Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF
Via InvestorPlace
Topics ETFs Initial Public Offering
Exposures Securities Market
2023's most anticipated IPOs weren't always the big winners
Via MarketBeat
Topics ETFs Initial Public Offering Stocks
Exposures Securities Market US Equities
European Private Equity CVC Capital Partners Defies Market Pessimism, Weighs Amsterdam IPO Next Week
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Instacart and Arm's Stock Decline Sparks Concerns Over Tech Sector IPOs
Via Benzinga
Arm Debut Gathers Retail Investors' Love: ETFs In Focus
Via Talk Markets
Topics ETFs
Instacart Targets Less Than $10B Valuation In Upcoming IPO, Significantly Lower Than Previous Funding Round
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Radiopharmaceuticals Startup RayzeBio Seeks Public Debut After Raising $400M From Investors
Via Benzinga
Healthcare Software Firm Waystar Goes IPO Way With Potential $8B Valuation
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
ETFs To Play The IPO Market Recovery
Via Talk Markets
Oddity Tech's AI-Powered Debut Sparks Optimism For '23 IPO Market
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Second Time Charm: Sagimet Biosciences Seeks Public Debut With $75M IPO
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.